Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Other Working Capital Changes: 2013-2020

Historic Other Working Capital Changes for Larimar Therapeutics (LRMR) over the last 7 years, with Dec 2020 value amounting to -$193,000.

  • Larimar Therapeutics' Other Working Capital Changes fell 111.85% to -$193,000 in Q4 2020 from the same period last year, while for Dec 2020 it was $1.6 million, marking a year-over-year decrease of 49.86%. This contributed to the annual value of $8.5 million for FY2024, which is 694.84% up from last year.
  • Per Larimar Therapeutics' latest filing, its Other Working Capital Changes stood at -$193,000 for Q4 2020, which was down 341.25% from $80,000 recorded in Q3 2020.
  • Over the past 5 years, Larimar Therapeutics' Other Working Capital Changes peaked at $1.8 million during Q2 2019, and registered a low of -$664,000 during Q4 2018.
  • For the 3-year period, Larimar Therapeutics' Other Working Capital Changes averaged around $394,417, with its median value being $45,500 (2020).
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first tumbled by 2,635.00% in 2018, then surged by 1,468.70% in 2019.
  • Quarterly analysis of 5 years shows Larimar Therapeutics' Other Working Capital Changes stood at -$157,000 in 2016, then soared by 49.04% to -$80,000 in 2017, then slumped by 730.00% to -$664,000 in 2018, then soared by 345.33% to $1.6 million in 2019, then tumbled by 111.85% to -$193,000 in 2020.
  • Its Other Working Capital Changes was -$193,000 in Q4 2020, compared to $80,000 in Q3 2020 and $1.7 million in Q2 2020.